Passaging the iPSCs gradually erased
those donor cell age - related epigenetic differences, the team found.
Not exact matches
The team also tested nanoparticle absorption for other kinds of human
cells, including fibroblasts from
donors of older
ages and found significant differences.
They received either a saline placebo or plasma — blood from which the red
cells have been removed — from blood
donors aged 18 — 30.
«We studied human T
cells, isolated from blood
donors of all
ages, to compare mature cytotoxic T
cells with naive ones,» said Philip Ansumana Hull, graduate student in Ott's lab and one of the first authors of the study.
In addition, recipients of red blood
cells from
donors aged 20 - 30 were associated with a six percent increased risk of death per transfused product compared with recipients of red blood
cells from
donors aged 40 - 50.
Recipients of blood from
donors aged 17 - 20 were associated with an eight percent increased risk of death per unit transfused compared with recipients of red blood
cells from
donors aged 40 - 50.
Inhibition of
cell division is also more pronounced with
donor age [8].
It is also pointed out that
donor age (beyond 45 years in the alkaline phosphatase - linked BrdU assays) may also have limited the human wounding response (
cell division) in the corneal periphery.
Would her
cells show the
age of the
donor or of a newborn?
Mehta J, Gordon LI, Tallman MS, et al., Does younger
donor age affect the outcome of reduced - intensity allogeneic hematopoietic stem
cell transplantation for hematologic malignancies beneficially?
To find out, the researchers examined methylation patterns in iPSCs derived from the peripheral blood mononuclear
cells of 16
donors,
ages 21 to 100.
Overall, the number of iPSC mutations — which the researchers suspect were present but undetected in
donor blood
cells — increased linearly with
donor age.
V. Lo Sardo et al., «Influence of
donor age on induced pluripotent stem
cells,» Nature Biotechnology, doi: 10.1038 / nbt.3749, 2016.
In order to study rescue effects following surgery,
donor cells were introduced at P21, an
age preceding major onset of photoreceptor loss.
To study the effect of
ageing on the ability of CMV - specific CD8 (+) T
cells to produce type 1 - and type 2 - cytokines, interferon - gamma - and IL -10-producing, CD8 (+) T
cell responses in the presence of CMV peptide antigen were measured in CMV - seropositive old and young
donors.
We have examined CD8 T
cell responses to two persistent herpesvirus infections, CMV and EBV, and to a recurrent virus infection, influenza, in different
age cohorts of healthy
donors using HLA - peptide tetramers and intracellular cytokine detection.
Upon transfer of
aged donor CD4 T
cells to young hosts, there was significantly reduced expansion and germinal center (GC) differentiation of the antigen - specific B
cell population after immunization.
The present study employed Ighb scid mice reconstituted with normal lymphocytes from young (2 -3-mo-old) and
aged (20 -25-mo-old)
donors and immunized with a protein conjugate of the hapten (4 - hydroxy -3-nitrophenyl) acetyl (NP) to determine whether the molecular changes in antibody repertoire reflect senescence in the B
cells or whether they are mediated by the
aging helper T lymphocytes.
When T
cells were donated by young mice, the anti-NP response in GC was dominated by the canonical V186.2 gene, even if the responder B
cells came from
aged donors.
To examine the effect of
age on the cognate function of CD4 T
cells, we have used a novel adoptive transfer model that allows us to compare identical numbers of antigen - specific naive T
cells from young and
aged TCR transgenic (Tg)
donors.
However, when the mice were reconstituted with T
cells from
aged donors, the expression of the V186.2 gene by young B
cells was diminished and the response was dominated by the C1H4 gene, another member of the V186.2 / V3 family.
The team conducted tests on three different samples of
cells aged in different ways:
cells taken from
aged donors,
cells aged in culture in the lab, and those isolated from patients suffering from Hutchinson - Gilford progeria syndrome, a rare genetic disorder that
ages sufferers at an accelerated rate.